Cargando…

P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY

Detalles Bibliográficos
Autores principales: Groen, K., Seefat, M., Nasserinejad, K., Stege, C. A., van der Spek, E., Bilgin, Y. M., Kentos, A., Sohne, M., van Kampen, R. J., Ludwig, I., Thielen, N., Durdu-Rayman, N., de Graauw, N. C., van de Donk, N. W., de Waal, E. G., Vekemans, M.-C., Timmers, G. J., van der Klift, M., Soechit, S., Geerts, P. A., Silbermann, M. H., Oosterveld, M., Nijhof, I., Sonneveld, P., Klein, S. K., Levin, M.-D., Zweegman, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430988/
http://dx.doi.org/10.1097/01.HS9.0000846496.51905.dd
_version_ 1784779928871370752
author Groen, K.
Seefat, M.
Nasserinejad, K.
Stege, C. A.
van der Spek, E.
Bilgin, Y. M.
Kentos, A.
Sohne, M.
van Kampen, R. J.
Ludwig, I.
Thielen, N.
Durdu-Rayman, N.
de Graauw, N. C.
van de Donk, N. W.
de Waal, E. G.
Vekemans, M.-C.
Timmers, G. J.
van der Klift, M.
Soechit, S.
Geerts, P. A.
Silbermann, M. H.
Oosterveld, M.
Nijhof, I.
Sonneveld, P.
Klein, S. K.
Levin, M.-D.
Zweegman, S.
author_facet Groen, K.
Seefat, M.
Nasserinejad, K.
Stege, C. A.
van der Spek, E.
Bilgin, Y. M.
Kentos, A.
Sohne, M.
van Kampen, R. J.
Ludwig, I.
Thielen, N.
Durdu-Rayman, N.
de Graauw, N. C.
van de Donk, N. W.
de Waal, E. G.
Vekemans, M.-C.
Timmers, G. J.
van der Klift, M.
Soechit, S.
Geerts, P. A.
Silbermann, M. H.
Oosterveld, M.
Nijhof, I.
Sonneveld, P.
Klein, S. K.
Levin, M.-D.
Zweegman, S.
author_sort Groen, K.
collection PubMed
description
format Online
Article
Text
id pubmed-9430988
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94309882022-08-31 P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY Groen, K. Seefat, M. Nasserinejad, K. Stege, C. A. van der Spek, E. Bilgin, Y. M. Kentos, A. Sohne, M. van Kampen, R. J. Ludwig, I. Thielen, N. Durdu-Rayman, N. de Graauw, N. C. van de Donk, N. W. de Waal, E. G. Vekemans, M.-C. Timmers, G. J. van der Klift, M. Soechit, S. Geerts, P. A. Silbermann, M. H. Oosterveld, M. Nijhof, I. Sonneveld, P. Klein, S. K. Levin, M.-D. Zweegman, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430988/ http://dx.doi.org/10.1097/01.HS9.0000846496.51905.dd Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Groen, K.
Seefat, M.
Nasserinejad, K.
Stege, C. A.
van der Spek, E.
Bilgin, Y. M.
Kentos, A.
Sohne, M.
van Kampen, R. J.
Ludwig, I.
Thielen, N.
Durdu-Rayman, N.
de Graauw, N. C.
van de Donk, N. W.
de Waal, E. G.
Vekemans, M.-C.
Timmers, G. J.
van der Klift, M.
Soechit, S.
Geerts, P. A.
Silbermann, M. H.
Oosterveld, M.
Nijhof, I.
Sonneveld, P.
Klein, S. K.
Levin, M.-D.
Zweegman, S.
P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_full P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_fullStr P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_full_unstemmed P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_short P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
title_sort p906: ixazomib, daratumumab and low dose dexamethasone in frail patients with newly diagnosed multiple myeloma (ndmm): results of the maintenance treatment of the phase ii hovon 143 study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430988/
http://dx.doi.org/10.1097/01.HS9.0000846496.51905.dd
work_keys_str_mv AT groenk p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT seefatm p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT nasserinejadk p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT stegeca p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT vanderspeke p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT bilginym p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT kentosa p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT sohnem p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT vankampenrj p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT ludwigi p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT thielenn p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT durduraymann p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT degraauwnc p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT vandedonknw p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT dewaaleg p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT vekemansmc p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT timmersgj p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT vanderkliftm p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT soechits p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT geertspa p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT silbermannmh p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT oosterveldm p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT nijhofi p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT sonneveldp p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT kleinsk p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT levinmd p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study
AT zweegmans p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study